Clinical Study Between Robotic and Open Surgery in Patients With Pancreatic Cancer
NCT04211948 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 300
Last updated 2021-04-09
Summary
The purpose of this study is to determine whether robotic surgery has limitations in terms of patient age, tumor size, location, and vascular relationship when compared to open surgery for pancreatic cancer. Whether robotic surgery has advantages over intraoperative bleeding, operative time, postoperative complications (bleeding, infection, pancreatic fistula) and postoperative hospital stays compared to open surgery.And the differences in lymph nodes harvest and postoperative survival between two groups.
Conditions
- Pancreatic Ductal Adenocarcinoma
- Minimally Invasive Surgery
Interventions
- PROCEDURE
-
robotic surgery
Pancreatectomy with robotic assisted system
- PROCEDURE
-
open surgery
Traditional open pancreatectomy
Sponsors & Collaborators
-
Shanghai Jiao Tong University School of Medicine
collaborator OTHER -
Ruijin Hospital
lead OTHER
Principal Investigators
-
Kai Qin · Ruijin Hospital
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- TREATMENT
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-03-01
- Primary Completion
- 2022-12-31
- Completion
- 2024-12-31
Countries
- China
Study Locations
More Related Trials
-
An Open-label, Multicenter, Prospective Study of Irreversible Electroporation (Nano Knife) Combined With Radiotherapy and Chemotherapy in Patients With Locally Advanced Pancreatic Cancer
NCT04310553 ·Status: UNKNOWN ·Phase: NA
-
Lymphadenectomy for Pancreatic Head Cancer: Standard or Extended?
NCT02787187 ·Status: COMPLETED ·Phase: NA
-
Conventional Partial Pancreatoduodenectomy Versus an Extended Pancreatoduodenectomy for Pancreatic Head Cancers
NCT06703905 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
The Therapeutic Evaluation(Both Short-term and Long-term Outcome) of Minimal Invasive Radical Antegrade Modular Pancreatosplenectomy for Left-sided Pancreatic Cancer Patients
NCT03770559 ·Status: UNKNOWN ·Phase: NA
-
Influence Factors of PD-1 Therapeutic Efficacy in Advanced Pancreatic Cancer
NCT05201729 ·Status: UNKNOWN
-
Surgery for Locally Unresectable Pancreatic Cancer
NCT07241663 ·Status: RECRUITING
-
RAMPS VS SRPS for Pancreatic Body and Tail Adenocarcinoma
NCT04253847 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
The Significance and Indications of Surgery for Synchronous Liver Metastatic Pancreatic Cancer
NCT06873178 ·Status: ACTIVE_NOT_RECRUITING
-
Study of Neoantigen mRNA Vaccines in Patients With Resectable Pancreatic Cancer
NCT06326736 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Risk Factors of Postoperative Complications and Survival Rate in Pancreatic Ductal Adenocarcinoma Patients
NCT06378853 ·Status: COMPLETED
-
Surgical Results of Resection of Locally Advanced Pancreatic Cancer
NCT06206382 ·Status: NOT_YET_RECRUITING
-
Nimotuzumab Combined With mFOLFIRINOX/GX as Postoperative Adjuvant Therapy in Pancreatic Cancer
NCT06389760 ·Status: RECRUITING ·Phase: PHASE2
-
Irreversible Electroporation Ablation Combined With Anti-PD(L)1 Therapy for Locally Advanced Pancreatic Cancer
NCT06677762 ·Status: NOT_YET_RECRUITING
-
In Vitro Organoid Drug Sensitivity-Guided Treatment for Advanced Pancreatic Neuroendocrine Tumor
NCT06246630 ·Status: RECRUITING ·Phase: NA
-
Combination of SBRT With Sequential S-1 for Treating Locally Advanced Pancreatic Cancer
NCT02704143 ·Status: COMPLETED ·Phase: NA
-
Investigating Targetable Metabolic Pathways Sustaining Pancreatic Cancer
NCT05296421 ·Status: RECRUITING ·Phase: NA
-
Clinical Study of mRNA Vaccine Combined With PD-1 Inhibitor as Adjuvant Therapy for Postoperative Pancreatic Cancer
NCT06496373 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
A Study of Extended Total Mesopancreas Excision(eTME) for Pancreatic Head Adenocarcinoma.
NCT04147403 ·Status: UNKNOWN
-
Standard Versus Extended Lymphadenectomy in Pancreatoduodenectomy for Patients With Pancreatic Head Adenocarcinoma
NCT02928081 ·Status: UNKNOWN ·Phase: NA
-
S-1 and and Gemcitabine vs Gemcitabine Alone as Adjuvant Chemotherapy for Patients With Resected Pancreatic Cancer
NCT02131493 ·Status: COMPLETED ·Phase: PHASE2
-
Extended Retroperitoneal Lymphadenectomy and Nerve Plexus Clearance Versus Standard Lymphadenectomy in Pancreaticoduodenectomy
NCT03081351 ·Status: UNKNOWN ·Phase: NA
-
A Retrospective Study for Nimotuzumab Plus Postoperative Adjuvant Chemotherapy for Resectable Pancreatic Cancer
NCT06363084 ·Status: COMPLETED
-
LRAMPS Versus LDP in Selected Early-stage Left-sided Pancreatic Cancer
NCT05939063 ·Status: RECRUITING ·Phase: NA
-
Pancreatic Head and Peri-ampullary Cancer Laparoscopic vs Open Surgical Treatment Trial (PLOT)
NCT02081131 ·Status: COMPLETED ·Phase: NA
-
Second-Line Adjuvant Therapy With Nab-Paclitaxel Plus Gemcitabine Versus Oxaliplatin Plus Folinic Acid and Fluorouracil for Gemcitabine-Refractory Pancreatic Cancer After Curative Resection
NCT02506842 ·Status: UNKNOWN ·Phase: PHASE3